| scholarly article | Q13442814 |
| P50 | author | David Eidelberg | Q5233311 |
| Phoebe G Spetsieris | Q58825556 | ||
| P2860 | cites work | A new look at the statistical model identification | Q26778401 |
| Statistical parametric maps in functional imaging: A general linear approach | Q27864122 | ||
| The diagnosis of Parkinson's disease | Q31026806 | ||
| Statistical limitations in functional neuroimaging. I. Non-inferential methods and statistical models | Q33178818 | ||
| Metabolic brain networks in neurodegenerative disorders: a functional imaging approach | Q33504970 | ||
| A regional covariance approach to the analysis of functional patterns in positron emission tomographic data | Q33517520 | ||
| Cortical hypometabolism and hypoperfusion in Parkinson's disease is extensive: probably even at early disease stages. | Q33548817 | ||
| Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease | Q33835425 | ||
| Abnormal regional brain function in Parkinson's disease: truth or fiction? | Q34160477 | ||
| Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI | Q34170874 | ||
| Thalamic metabolism and symptom onset in preclinical Huntington's disease | Q34692568 | ||
| Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease | Q34770504 | ||
| Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease | Q35679727 | ||
| Changes in network activity with the progression of Parkinson's disease | Q35679748 | ||
| Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease | Q35679817 | ||
| Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. | Q35683286 | ||
| Metabolic brain networks associated with cognitive function in Parkinson's disease | Q35684482 | ||
| Network modulation in the treatment of Parkinson's disease | Q35694166 | ||
| Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis | Q36198606 | ||
| Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease | Q36288717 | ||
| Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease | Q36739358 | ||
| Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias | Q36990181 | ||
| Network biomarkers for the diagnosis and treatment of movement disorders | Q37327010 | ||
| Three-fold cross-validation of parkinsonian brain patterns | Q43597155 | ||
| Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism | Q44237894 | ||
| Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease | Q44418055 | ||
| Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. | Q44428226 | ||
| The metabolic pathology of dopa-responsive dystonia | Q46399764 | ||
| FDG PET in the differential diagnosis of parkinsonian disorders | Q46546312 | ||
| Metabolic correlates of subthalamic nucleus activity in Parkinson's disease | Q46653986 | ||
| Abnormal metabolic networks in atypical parkinsonism | Q46815002 | ||
| Reproducibility of regional metabolic covariance patterns: comparison of four populations. | Q48134047 | ||
| Quantification of Parkinson's disease-related network expression with ECD SPECT. | Q48374366 | ||
| Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing | Q48552859 | ||
| Normalization in PET group comparison studies--the importance of a valid reference region. | Q53436547 | ||
| The Scree Test For The Number Of Factors | Q56210944 | ||
| The metabolic topography of parkinsonism | Q72136177 | ||
| Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET | Q72616594 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| statistical model | Q3284399 | ||
| P1104 | number of pages | 16 | |
| P304 | page(s) | 2899-2914 | |
| P577 | publication date | 2010-10-20 | |
| P1433 | published in | NeuroImage | Q1981225 |
| P1476 | title | Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues | |
| Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues | |||
| P478 | volume | 54 |
| Q34399253 | A disease-specific metabolic brain network associated with corticobasal degeneration |
| Q92992113 | A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia |
| Q52099611 | Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample. |
| Q35866836 | Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism |
| Q37658353 | Abnormal metabolic network activity in REM sleep behavior disorder |
| Q36267429 | Abnormal metabolic pattern associated with cognitive impairment in Parkinson's disease: a validation study |
| Q36326985 | Abnormal network topographies and changes in global activity: absence of a causal relationship |
| Q96303197 | Brain Functional and Structural Signatures in Parkinson's Disease |
| Q38254740 | Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease |
| Q37834193 | Brain networks in Huntington disease |
| Q30409274 | Cerebral blood flow and gray matter volume covariance patterns of cognition in aging |
| Q42019841 | Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners |
| Q30940145 | Classification of Parkinsonian syndromes from FDG-PET brain data using decision trees with SSM/PCA features |
| Q91670190 | Correlations of Neuropsychological and Metabolic Brain Changes in Parkinson's Disease and Other α-Synucleinopathies |
| Q36688444 | Differences between chronological and brain age are related to education and self-reported physical activity |
| Q39318829 | Distinct brain networks underlie cognitive dysfunction in Parkinson and Alzheimer diseases |
| Q40875715 | Dopaminergic correlates of metabolic network activity in Parkinson's disease |
| Q58789390 | FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease |
| Q38666938 | FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder |
| Q37277039 | Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesia |
| Q34114125 | Functional brain networks and abnormal connectivity in the movement disorders |
| Q34308197 | Functional brain networks in movement disorders: recent advances |
| Q27013767 | Functional neuroimaging in Parkinson's disease |
| Q60302443 | Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes |
| Q57460436 | Gray Matter Volume Covariance Networks Associated with Social Networks in Older Adults |
| Q91140150 | Gray matter volume covariance networks associated with dual-task cost during walking-while-talking |
| Q52599329 | Gray matter volume covariance patterns associated with gait speed in older adults: a multi-cohort MRI study. |
| Q30655192 | Identification of disease-related spatial covariance patterns using neuroimaging data |
| Q92882867 | Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson's disease using 18F-FDG PET imaging |
| Q57089239 | Impact of Global Mean Normalization on Regional Glucose Metabolism in the Human Brain |
| Q36020017 | Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation |
| Q55223963 | Intra- and Inter-scanner Reliability of Scaled Subprofile Model of Principal Component Analysis on ALFF in Resting-State fMRI Under Eyes Open and Closed Conditions. |
| Q64235539 | Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment |
| Q36041821 | Metabolic brain networks in translational neurology: concepts and applications |
| Q49066177 | Metabolic connectivity for differential diagnosis of dementing disorders. |
| Q37123932 | Metabolic network as a progression biomarker of premanifest Huntington's disease |
| Q48829872 | Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations |
| Q35134794 | Metabolic resting-state brain networks in health and disease |
| Q47632627 | Network Structure and Function in Parkinson's Disease. |
| Q35883193 | Network correlates of disease severity in multiple system atrophy |
| Q35183576 | Network correlates of the cognitive response to levodopa in Parkinson disease |
| Q33944241 | Network modulation following sham surgery in Parkinson's disease. |
| Q33676222 | Neuroimaging in pre-motor Parkinson's disease |
| Q36901626 | Parkinson's disease cognitive network correlates with caudate dopamine |
| Q39748050 | Parkinson's disease-related network topographies characterized with resting state functional MRI. |
| Q33949592 | Parkinson's disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging |
| Q36254327 | Parkinson's disease-related spatial covariance pattern identified with resting-state functional MRI. |
| Q36899657 | Parkinson's disease: increased motor network activity in the absence of movement |
| Q37539435 | Quantifying significance of topographical similarities of disease-related brain metabolic patterns |
| Q37068138 | Regional covariance patterns of gray matter alterations in Alzheimer's disease and its replicability evaluation |
| Q52656677 | Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts. |
| Q48104749 | The Alzheimer's disease metabolic brain pattern in mild cognitive impairment |
| Q55714779 | The cerebral metabolic topography of spinocerebellar ataxia type 3. |
| Q47975812 | The effect of 18F-FDG-PET image reconstruction algorithms on the expression of characteristic metabolic brain network in Parkinson's disease |
| Q47907731 | Validation of parkinsonian disease-related metabolic brain patterns |
Search more.